What Does Proteros Biostructures GmbH Do?

Total employees179
HeadquartersMartinsried/Planegg
Founded1997

Proteros Biostructures GmbH is a Germany-based, privately-held company specializing in integrated structure-based drug discovery. They offer a comprehensive suite of services, including protein production and purification, X-ray crystallography, biophysical interaction analysis (SPR, ITC, DSF/nanoDSF, MST), fragment-based lead discovery (FBLD), and medicinal chemistry for lead optimization. Proteros supports pharmaceutical and biotech companies worldwide by providing high-quality structural information and hit-to-lead services to accelerate drug development programs. The company leverages its proprietary technologies and expertise in areas like membrane proteins and challenging targets. In 2021, Proteros was acquired by WuXi AppTec.

Where Is Proteros Biostructures GmbH's Headquarters?

HQ Function

The headquarters serves as the central hub for research and development, laboratory operations, corporate administration, and client project management for its global drug discovery services.

Notable Features:

State-of-the-art laboratories equipped for protein sciences, X-ray crystallography, biophysical screening, and computational chemistry. Its location within the IZB (Innovation and Start-up Center for Biotechnology) in Martinsried provides access to a vibrant scientific community and infrastructure.

Work Culture:

The work culture at Proteros is highly scientific, collaborative, and innovation-focused, driven by a team of experienced researchers and technicians dedicated to advancing drug discovery projects. Emphasis is placed on precision, quality, and scientific rigor.

HQ Significance:

The Martinsried headquarters is significant due to its advanced R&D capabilities and its position within one of Europe's leading biotech clusters, fostering innovation and collaboration.

Values Reflected in HQ: The headquarters reflects Proteros' commitment to cutting-edge science, technological excellence, and providing high-quality solutions to the pharmaceutical industry.

Location:

Proteros Biostructures GmbH operates globally, serving clients in the pharmaceutical and biotechnology sectors across Europe, North America, and Asia from its main research facilities in Germany. Its specialized services in structure-based drug discovery, including protein production, crystallography, biophysical analysis, and lead generation, support drug discovery programs worldwide. The US office in San Diego enhances its ability to serve the North American market.

Street Address:

Bunsenstr. 7a

City:

Martinsried/Planegg

State/Province:

Bavaria

Country:

Germany

Where Else Does Proteros Biostructures GmbH Operate Around the World?

San Diego, CA/USA

Address: 10578 Science Center Drive, Suite 150, San Diego, CA 92121

To strengthen Proteros' presence in the significant North American market, foster collaborations with US-based companies, and provide local support for ongoing projects.

Buying Intent Signals for Proteros Biostructures GmbH

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Proteros Biostructures GmbH? Meet the Executive Team

As of April 2025, Proteros Biostructures GmbH' leadership includes:

Dr. Torsten Neuefeind - Chief Executive Officer
Dr. Gerhard MĂĽller - Chief Scientific Officer
Dr. Peter Reinemer - Chief Operating Officer
Konstanze Haupt - Chief Financial Officer

Who's Investing in Proteros Biostructures GmbH?

Proteros Biostructures GmbH has been backed by several prominent investors over the years, including:

WuXi AppTec (Parent Company since 2021)
MIG Capital AG (Previous Investor)
KfW Bankengruppe (Previous Investor)
Bayern Kapital (Previous Investor)

What Leadership Changes Has Proteros Biostructures GmbH Seen Recently?

Hire0
Exits0

No major C-level executive hires or exits have been publicly announced for Proteros Biostructures GmbH in the last 12 months. The leadership team appears stable following its acquisition by WuXi AppTec in 2021.

What Technology (Tech Stack) Is Used byProteros Biostructures GmbH?

Discover the tools Proteros Biostructures GmbH uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Proteros Biostructures GmbH Email Formats and Examples

Proteros Biostructures GmbH likely utilizes common corporate email formats. Based on typical German company structures and individuals listed on their website or LinkedIn, common patterns include [first_initial][last_name]@proteros.com or [first_name].[last_name]@proteros.com.

[first_initial][last_name]@proteros.com or [first_name].[last_name]@proteros.com

Format

tneuefeind@proteros.com or gerhard.mueller@proteros.com

Example

80%

Success rate

What's the Latest News About Proteros Biostructures GmbH?

WuXi AppTec • May 19, 2021

Proteros Biostructures GmbH news title: WuXi AppTec Acquires Proteros, a Leader in Structure-Based Drug Discovery

WuXi AppTec announced its acquisition of Proteros Biostructures GmbH, a Germany-based contract research organization renowned for its expertise in structure-based drug discovery. This acquisition aims to enhance WuXi AppTec's capabilities in hit generation and lead optimization....more

European Pharmaceutical Review • October 26, 2023

Proteros Biostructures GmbH news title: Proteros and Evariste Galois announce collaboration for AI drug discovery

Proteros Biostructures and Evariste Galois have entered a collaboration to combine Proteros’ structure-based drug discovery platform with Evariste Galois’ AI technology (Generative AI: GAI) for novel drug design. The goal is to accelerate the identification and optimization of new drug candidates....more

Proteros Biostructures GmbH (via LinkedIn) • September 1, 2022

Proteros Biostructures GmbH news title: Proteros Expands Cryo-EM Capabilities

Proteros announced the expansion of its Cryo-Electron Microscopy (Cryo-EM) capabilities, further strengthening its structural biology platform to support drug discovery for complex protein targets. This enhancement allows for high-resolution structure determination of challenging molecules....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Proteros Biostructures GmbH, are just a search away.